Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice
about
Angiotensin-(1-7): new perspectives in atherosclerosis treatmentVascular endothelial dysfunction and pharmacological treatmentUpregulation of Angiotensin (1-7)-Mediated Signaling Preserves Endothelial Function Through Reducing Oxidative Stress in Diabetes.Angiotensin II-induced mitochondrial Nox4 is a major endogenous source of oxidative stress in kidney tubular cellsSuppression of XBP1S mediates high glucose-induced oxidative stress and extracellular matrix synthesis in renal mesangial cell and kidney of diabetic rats.Beneficial effects of long-term administration of an oral formulation of Angiotensin-(1-7) in infarcted rats.Angiotensin-(1-7) inhibits epidermal growth factor receptor transactivation via a Mas receptor-dependent pathway.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Regulation of Dopamine Uptake by Vasoactive Peptides in the Kidney.Identification of Cofilin-1 Induces G0/G1 Arrest and Autophagy in Angiotensin-(1-7)-treated Human Aortic Endothelial Cells from iTRAQ Quantitative Proteomics.Role of the receptor Mas in macrophage-mediated inflammation in vivo.The renin-angiotensin system, bone marrow and progenitor cells.Signaling pathways of apoE and its role of gene expression in glomerulus diseases.Angiotensin-(1-7) and angiotensin-(1-9): function in cardiac and vascular remodelling.Signaling pathway factors expression in renal tissue of apoE-knockout mice.Macrophages in neuroinflammation: role of the renin-angiotensin-system.Complete blockade of the vasorelaxant effects of angiotensin-(1-7) and bradykinin in murine microvessels by antagonists of the receptor Mas.Prolonged treatment with angiotensin 1-7 improves endothelial function in diet-induced obesity.Reversal of Bone Marrow Mobilopathy and Enhanced Vascular Repair by Angiotensin-(1-7) in Diabetes.Chronic p38 mitogen-activated protein kinase inhibition improves vascular function and remodeling in angiotensin II-dependent hypertension.Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).Angiotensin-(1-7)-induced activation of ERK1/2 is cAMP/protein kinase A-dependent in glomerular mesangial cells.
P2860
Q26770846-C8C60A3A-85DB-4D56-9B16-E9877C323D4BQ26774561-7E420BE6-CE04-43C8-915E-92C211EF76D3Q27308039-6E62ED4F-AF73-4982-895E-098CF866A972Q34341622-4EA56352-6D04-48E3-B26F-5255A0FDD7E6Q34606527-A6B50AE6-C6B4-4378-9EBE-F9D4FC0EAD22Q35811007-E9D07FAA-FFFB-4702-A2D7-DC434D755DF8Q36024889-1A3B099D-6923-4433-891C-7EDC584FE129Q36241932-D647F8BF-2F9E-47F6-9217-0E4BDE71C0ECQ37231706-71B8412D-FBAB-41F0-B1C8-8BF5F50BAE6CQ37343187-2BC9E979-BE0C-46C6-BD7B-22FA9DAEAE80Q37493351-8B60004A-179A-40A3-ADEE-88DE31A5AF55Q38006725-B7C84306-7C51-4463-A7F0-82B369F18AE9Q38079285-A37AF73F-484C-4C24-BADD-ADBD939AF5C9Q38193206-B8DEE895-8F80-4545-BAF8-DF81695AE9CCQ38533698-F47DB8BD-5325-46D9-B0D4-BA6B10A6B825Q38965333-A9AF217A-4F41-42AB-A91B-27C98FF2CD8DQ44985835-CE8650C1-FF74-472E-9A0E-0261317791D5Q46205392-64C78AA4-A95D-4DAF-B3ED-8F568E7763F2Q51321906-A21DDB11-5DCF-43BD-850D-58CA3D0F3290Q51645576-96742062-D0A1-4AB5-8A4A-9039C25B6DEFQ54326718-41CAF7F6-D405-4CF8-8F0D-AB9EE42F3889Q54541508-783AA2E6-8F11-4AA6-A64E-FA31AA040195
P2860
Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoproteinE-deficient mice
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chronic treatment with angiote ...... apolipoproteinE-deficient mice
@ast
Chronic treatment with angiote ...... apolipoproteinE-deficient mice
@en
type
label
Chronic treatment with angiote ...... apolipoproteinE-deficient mice
@ast
Chronic treatment with angiote ...... apolipoproteinE-deficient mice
@en
prefLabel
Chronic treatment with angiote ...... apolipoproteinE-deficient mice
@ast
Chronic treatment with angiote ...... apolipoproteinE-deficient mice
@en
P2093
P2860
P1476
Chronic treatment with angiote ...... apolipoproteinE-deficient mice
@en
P2093
E Königshausen
J Stegbauer
M Woznowski
S A Potthoff
S Friedrich
P2860
P304
P356
10.1111/J.1476-5381.2011.01295.X
P407
P577
2011-07-01T00:00:00Z